Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use

AIDS ◽  
2000 ◽  
Vol 14 (2) ◽  
pp. F17-F23 ◽  
Author(s):  
Horacio Salomon ◽  
Mark A Wainberg ◽  
Bluma Brenner ◽  
Yudong Quan ◽  
Danielle Rouleau ◽  
...  
2019 ◽  
Vol 5 (2) ◽  
Author(s):  
Ownby RL ◽  
Waldrop-Valverde D ◽  
Kumar AM ◽  
Jones D ◽  
Fernandez B ◽  
...  

2018 ◽  
Vol 34 (10) ◽  
pp. 867-878 ◽  
Author(s):  
Elena Dukhovlinova ◽  
Alexey Masharsky ◽  
Aleksandra Vasileva ◽  
Alessandro Porrello ◽  
Shuntai Zhou ◽  
...  

2008 ◽  
Vol 49 (12) ◽  
pp. 1999-2005 ◽  
Author(s):  
M. F. Georgiou ◽  
A. Gonenc ◽  
D. Waldrop-Valverde ◽  
R. A. Kuker ◽  
S. H. Ezuddin ◽  
...  

2021 ◽  
Vol 18 (1) ◽  
Author(s):  
Alexandra Dmitrieva ◽  
Vladimir Stepanov ◽  
Kateryna Svyrydova ◽  
Ievgeniia-Galyna Lukash ◽  
Svetlana Doltu ◽  
...  

Abstract Introduction In 2007, the World Health Organization (WHO) recommended for prison authorities to introduce prison needle and syringe programs (PNSP) if they have any evidence that injecting drug use is taking place in prisons. This article presents descriptive evidence that injecting drug use takes place in Ukrainian prisons, it discusses how (denial of) access to injection equipment is regulated in the current system and what changes should be considered in order to implement PNSP. Background Ukrainian prisons still live by the laws and policies adopted in the Soviet Union. Besides laws and regulations, these legacies are replicated through the organization and infrastructure of the prison’s physical space, and through “carceral collectivism” as a specific form of living and behaving. Inviolability of the prison order over time helps the prison staff to normalize and routinely rationalize punishment enforcement as a power “over” prisoners, but not a power “for” achieving a specific goal. Methods The Participatory Action Research approach was used as a way of involving different actors in the study’s working group and research process. The data were gathered through 160 semi-structured interviews with prison health care workers, guards, people who inject drugs (PWID) who served one or several terms and other informants. Results The “expertise” in drug use among prisoners demonstrated by prison staff tells us two things—they admit that injecting use takes place in prisons, and that the surveillance of prisoner behavior has been carried out constantly since the very beginning as a core function of control. The communal living conditions and prison collectivism may not only produce and reproduce a criminal subculture but, using the same mechanisms, produce and reproduce drug use in prison. The “political will” incorporated into prison laws and policies is essential for the revision of outdated legacies and making PNSP implementation feasible. Conclusion PNSP implementation is not just a question of having evidence of injecting drug use in the hands of prison authorities. For PNSP to be feasible in the prison environment, there is a need for specific changes to transition from one historical period and political leadership to another. And, thus, to make PNSP work requires making power work for change, and not just for reproducing the power itself.


Author(s):  
Bernadien M. Nijmeijer ◽  
Marta Bermejo-Jambrina ◽  
Tanja M. Kaptein ◽  
Carla M. S. Ribeiro ◽  
Doris Wilflingseder ◽  
...  

AbstractSemen is important in determining HIV-1 susceptibility but it is unclear how it affects virus transmission during sexual contact. Mucosal Langerhans cells (LCs) are the first immune cells to encounter HIV-1 during sexual contact and have a barrier function as LCs are restrictive to HIV-1. As semen from people living with HIV-1 contains complement-opsonized HIV-1, we investigated the effect of complement on HIV-1 dissemination by human LCs in vitro and ex vivo. Notably, pre-treatment of HIV-1 with semen enhanced LC infection compared to untreated HIV-1 in the ex vivo explant model. Infection of LCs and transmission to target cells by opsonized HIV-1 was efficiently inhibited by blocking complement receptors CR3 and CR4. Complement opsonization of HIV-1 enhanced uptake, fusion, and integration by LCs leading to an increased transmission of HIV-1 to target cells. However, in the absence of both CR3 and CR4, C-type lectin receptor langerin was able to restrict infection of complement-opsonized HIV-1. These data suggest that complement enhances HIV-1 infection of LCs by binding CR3 and CR4, thereby bypassing langerin and changing the restrictive nature of LCs into virus-disseminating cells. Targeting complement factors might be effective in preventing HIV-1 transmission.


The Lancet ◽  
1999 ◽  
Vol 353 (9168) ◽  
pp. 1974 ◽  
Author(s):  
Rita Murri ◽  
Adriana Ammassari ◽  
Andrea De Luca ◽  
Antonella Cingolani ◽  
Andrea Antinori
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document